5Wrong R,Malthaner R.Combined chemotherapy and radiotherapy(without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus[J].Cochrane Database Syst Rev,2006,25(1):23.
9[1]Somasundaram R,Jacob L,Swoboda R,et al.Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta[J].Cancer Res,2002,62(18):5267-5272.
10[4]Nair RE,Kilinc MO,Jones SA,et al.Chronic Immune Therapy Induces a Progressive Increase in Intratumoral T Suppressor Activity and a Concurrent Loss of Tumor-Specific CD8+ T Effectors in her-2/neu Transgenic Mice Bearing Advanced Spontaneous Tumors[J].J Immunol,2006,176(12):7325-7334.
5Cox JD, Stetz Pajak TF. Toxicity critrria of the Ontology (RTOG)and the ropean Organization for Research and Treatment of Cancer (EORTC)[J ]. Int J Radiat oneol Biolys, 1995, 31: 1341.
6Beglan KL,Fraxier RC,Yan D,et al.The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer[J].Int J Radiat oncol Boil phys,2002,52(1):176.
8Tanabe S,Naomoto Y,Shirakawa Y,et al.F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma[J].Clin Nucl Med,2011,36(10):854-859.
9Muijs CT,Schreurs LM,Busz DM,et al.Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer[J].Radiother Oncol,2009,93(3):447-453.
10Hou DL,Shi GF,Gao XS,et al.Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma[J].Radiat Oncol,2013,8(1):169-176.
